Phibro Animal Health reported $948.38M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Align Technology ALGN:US USD 5.91B 102.68M
Ani Pharmaceuticals ANIP:US USD 739.11M 12.22M
Aurora Cannabis Inc ACB:CN CAD 1.17B 85.57M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Canopy Growth Corp WEED:CN CAD 3.4B 115.26M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Depomed DEPO:US USD 323.34M 1.37M
Eli Lilly And LLY:US USD 47.46B 397.9M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Henry Schein HSIC:US USD 8.53B 210M
Idexx Laboratories IDXX:US USD 2.64B 32.88M
Knight Therapeutics Inc GUD:CN CAD 1.04B 34.21M
Lannett LCI:US USD 467.3M 17.14M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Patterson Companies PDCO:US USD 2.88B 122.1M
Phibro Animal Health PAHC:US USD 948.38M 16.68M
Prestige Brands PBH:US USD 3.68B 3.72M
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B
Zoetis ZTS:US USD 13.67B 96M